|
"popat sanjay"的相關文件
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2022-05-14T23:35:41Z |
Tyrosine Kinase Inhibitor Activity in Patients with NSCLC Harboring Uncommon EGFR Mutations: A Retrospective International Cohort Study (UpSwinG)
|
Popat, Sanjay; Hsia, Te Chun; Hung, Jen Yu; Jung, Hyun Ae; JIN-YUAN SHIH; Park, Cheol Kyu; Lee, Seung Hyeun; Okamoto, Tatsuro; Ahn, Hee Kyung; Lee, Yong Chul; Sato, Yuki; Lee, Sung Sook; Mascaux, Celine; Daoud, Hasan; Märten, Angela; Miura, Satoru |
| 中山醫學大學 |
2017-04 |
Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit
|
Dionysis, Papadatos-Pastos; Roda, Desam; Luken, Maria Jose De Miguel; Petruckevitch, Ann; Jalil, Awais; Capelan, Marta; Michalarea, Vasiliki; Joao Lima, Nikolaos Diamantis; Bhosle, Jaishree; Molife, L. Rhoda; Banerji, Udai; Bono, Johann S. de; Popat, Sanjay; O'Brien, Mary E.R.; Yap, Timothy A. |
| 國立臺灣大學 |
2015 |
Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
|
Yang, James Chih-Hsin; Wu, Yi-Long; Schuler, Martin; Sebastian, Martin; Popat, Sanjay; Yamamoto, Nobuyuki; Zhou, Caicun; Hu, Cheng-Ping; O'Byrne, Kenneth; Feng, Jifeng; Lu, Shun; Huang, Yunchao; Geater, Sarayut L.; Lee, Kye Young; Tsai, Chun-Ming; Gorbunova, Vera; Hirsh, Vera; Bennouna, Jaafar; Orlov, Sergey; Mok, Tony; Boyer, Michael; Su, Wu-Chou; Lee, Ki Hyeong; Kato, Terufumi; Massey, Dan; Shahidi, Mehdi; Zazulina, Victoria; Sequist, Lecia V.; 楊志新 |
| 國立臺灣大學 |
2015 |
TIGER-3: A phase 3, open-label, randomized study of rociletinib vs cytotoxic chemotherapy in patients (pts) with mutant EGFR non-small cell lung cancer (NSCLC) progressing on prior EGFR TKI therapy and doublet chemotherapy.
|
Yang, James Chih-Hsin; Popat, Sanjay; Georgiou, Panos; Miyamoto, Emiko; Isaacson, Jeffrey D.; Wakelee, Heather A.; 楊志新 |
顯示項目 1-4 / 4 (共1頁)
1
每頁顯示[10|25|50]項目
|
